Evaluation of community pharmacy service mix: Evidence from the 2004 National Pharmacist Workforce Study

Journal of the American Pharmacists Association

Volumn 46, Issue 3, 2006, Pages 348-355

  Doucette, William R ^a   Kreling, David H ^b   Schommer, Jon C ^c   Gaither, Caroline A ^d   Mott, David A ^b   Pedersen, Craig A ^e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Community and ambulatory pharmacy; Entrepreneurship; Innovation; Pharmaceutical care; Pharmacy services

Indexed keywords

ARTICLE; COMMERCIAL PHENOMENA; DIABETES MELLITUS; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; IMMUNIZATION; JOB ANALYSIS; MASS SCREENING; OUTCOME ASSESSMENT; PARTTIME EMPLOYMENT; PHARMACIST; PHARMACY; QUESTIONNAIRE; SMOKING CESSATION; WORKPLACE; CROSS-SECTIONAL STUDY; DISEASE MANAGEMENT; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE;

COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; HUMANS; PREVENTIVE HEALTH SERVICES;

EID: 33745151448     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434506777069471     Document Type: Article

References (29)

1. West DS. NCPA-Pfizer digest 2004. Alexandria, Va.: National Community Pharmacists Association; 2004.
2. Ernst ME, Doucette WR, Dedhiya SD, et al. Use of point-of-service health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders. Pharmacotherapy. 2001;21:988-97.
3. Kassam R, Farris KB, Burback L, et al. Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc. 2001;41:401-10.
4. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713-9.
5. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
6. Cardina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21:1196-1203.
7. Tsukuki RT, Johnson JA, Teo KK, et al. Study of cardiovascular risk intervention by pharmacists (SCRIP): a randomized trial design of the effect of community pharmacist intervention program on serum cholesterol risk. Ann Pharmacother. 1999;33:910-9.
8. Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy. 2001;1:627-35.
9. Kennedy DT, Giles JT, Chang ZG, et al. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:51-6.
10. Knowiton CH, Thomas OV, Williamson A, et al. Establishing community-based anticoagulation education and monitoring programs. J Am Pharm Assoc. 1999;39:368-74.
11. McCurdy M. Oral anticoagulation monitoring in a community pharmacy. Am Pharm. 1993;10:61-70.
12. Elliott ME, Meek PD, Kanous NL, et al. Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc. 2002;42:101-10.
13. Tice B, Phillips CR. Implementation and evaluation of a lipid screening program in a large chain pharmacy. J Am Pharm Assoc. 2002;42:413-9.
14. Swain JH, Macklin R. Individualized diabetes care in a rural community pharmacy. J Am Pharm Assoc. 2001;41:458-61.
15. Berringer R, Shibley MC, Cary CC, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791-7.
16. Baran RW, Crumlish K, Patterson H, et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm. 1999;56:1535-9.
17. McDermott JH, Christensen DB. Provision of pharmaceutical care services in North Carolina: a 1999 survey. J Am Pharm Assoc. 2002;42:26-35.
18. Doucette WR, Jambulingam T. Pharmacy entrepreneurial orientation: antecedents and its effect on the provision of innovative pharmacy services. J Soc Admin Pharm. 1999;16:26-37.
19. Law AV, Okamoto MP, Chang PS. Prevalence and types of disease management programs in community pharmacies in California. J Managed Care Pharm. 2005;11:505-12.
20. Lumpkin GT, Dess GG. Clarifying the entrepreneurial orientation construct and linking it to performance. Acad Manage Rev. 1996;21(1):135-172.
21. Hunt SD, Morgan RM. The comparative advantage theory of competition. J Market. 1995(Apr);59:1-15.
22. Vanhaverbeke W, Peelers N. Embracing innovation as strategy: corporate venturing, competence building and corporate strategy making. Creativity Innov Manage. 2005;14:246-57.
23. Van Looy B, Martens T, Debackere K. Organizing for continuous innovation: on the sustainability of ambidextrous organizations. Creativity Innov Manage. 2005;14:208-21.
24. Barney J. Firm resources and sustained competitive advantage. J Manage. 1991;17(1):99-120.
25. Iyer S, Doucette WR. The influence of environmental attributes on the relationship between entrepreneurial orientation and performance in independent community pharmacies. J Pharm Market Manage. 2003;15(2):25-46.
26. McDonough RP, Doucette WR. Developing collaborative working relationships with physicians. J Am Pharm Assoc. 2001;41:682-92.
27. Rogers EM. Diffusion of innovation, 4th ed. New York: Free Press; 1995.
28. The 2004 supermarket pharmacy survey. Washington, D.C.: Food Marketing Institute; 2004.
29. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (Version 1.0). J Am Pharm Assoc. 2005;45:573-9.